StemBioSys, Inc. based in San Antonio, Texas, is a privately-held biomedical company focused on enhancing the growth and delivery of adult stem cells for research, therapeutic or drug discovery applications. Its patented and proprietary technology platforms – licensed from the UT Systems– overcome key obstacles to creating clinically useful stem cell therapies. The centerpiece of these enabling technologies is the HPME® (High Performance Micro Environment) platform. This cell derived 3-dimensional microenvironment allows a variety of stem cells to replicate more rapidly, maintain a small cell size and express markers indicative of retained stem cell potency beyond that seen with traditional tissue culture substrates. This year, StemBioSys will announce a new advanced version of its cell expansion technology and specialized cell lines enabled by this technology. Our products are available for the research market in the United States through VWR.
StemBioSys, Inc. is actively seeking collaborations with partners looking for cell expansion technologies.